Global Bone Marrow Transplantation Analysis and Market Growth, Trend, Research, Study and Forecast 2014

MarketResearchReports.Biz announces addition of new report “AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014” to its database. Visit: http://www.marketresearchreports.biz/analysis/187350.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketResearchReports.biz

MarketResearchReports.biz

Albany, NY (PRWEB) February 18, 2014

Global Markets Directs, 'AIDS Related Kaposi's Sarcoma Pipeline Review, H1 2014', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for AIDS Related Kaposi's Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS Related Kaposi's Sarcoma. AIDS Related Kaposi's Sarcoma Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Browse Complete report with TOC: http://www.marketresearchreports.biz/analysis-details/aids-related-kaposis-sarcoma-pipeline-review-h1-2014.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

A snapshot of the global therapeutic scenario for AIDS Related Kaposi's Sarcoma.
A review of the AIDS Related Kaposi's Sarcoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Coverage of products based on various stages of development ranging from discovery till registration stages.
A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Coverage of the AIDS Related Kaposi's Sarcoma pipeline on the basis of route of administration and molecule type.
Key discontinued pipeline projects.
Latest news and deals relating to the products.

To Download Sample Report Visit: http://www.marketresearchreports.biz/sample/sample/187350.

Reasons to buy

Identify and understand important and diverse types of therapeutics under development for AIDS Related Kaposi's Sarcoma.
Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
Devise corrective measures for pipeline projects by understanding AIDS Related Kaposi's Sarcoma pipeline depth and focus of Indication therapeutics.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table of Contents

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
AIDS - Related Kaposi\'s Sarcoma Overview
Therapeutics Development
Pipeline Products for AIDS - Related Kaposi\'s Sarcoma - Overview
Pipeline Products for AIDS - Related Kaposi\'s Sarcoma - Comparative Analysis
AIDS - Related Kaposi\'s Sarcoma - Therapeutics under Development by Companies
AIDS - Related Kaposi\'s Sarcoma - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
AIDS - Related Kaposi\'s Sarcoma - Products under Development by Companies
AIDS - Related Kaposi\'s Sarcoma - Companies Involved in Therapeutics Development
Aphios Corporation
CytRx Corporation
Cannabis Science, Inc.
Xiamen Amoytop Biotech Co., Ltd.
Biogenomics

To buy this Report: http://www.marketresearchreports.biz/analysis/187350.

AIDS - Related Kaposi\'s Sarcoma - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Assessment by Therapeutic Class
Drug Profiles
aldoxorubicin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
paclitaxel nanosomal - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CS-TATI- - Drug Profile
Product Description
Mechanism of Action
R&D Progress
interferon alfa-a biosimilar - Drug Profile
Product Description
Mechanism of Action
R&D Progress
interferon alfa-b - Drug Profile
Product Description
Mechanism of Action
R&D Progress
interferon alfa-a - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AIDS - Related Kaposi\'s Sarcoma - Recent Pipeline Updates
AIDS - Related Kaposi\'s Sarcoma - Dormant Projects
AIDS - Related Kaposi\'s Sarcoma - Discontinued Products
AIDS - Related Kaposi\'s Sarcoma - Product Development Milestones
Featured News & Press Releases

Oct 08, 2012: J&J Files Applications Seeking US And EU Approvals For New Manufacturing Process Of Doxil
Oct 25, 2006: Eisai Announces Completion of Acquisition of Four Oncology-Related Products from Ligand
Sep 07, 2006: Eisai Acquires Four Oncology-Related Products from Ligand
Feb 07, 2005: U.S. FDA grants full approval to DOXIL following submission of Phase III data
Jul 17, 2000: European CPMP Recommendes the approval of Ligand\'s Panretin Gel
Jan 06, 2000: Alfa Wassermann has agreement with Ligand for the marketing and distribution of Ontak, Targretin and Panretin
Apr 15, 1999: Supplemental NDA for Alza\'s Doxil in refractory ovarian cancer granted priority review.
Mar 30, 1999: Ligand and Ferrer Entered Into agreement for Marketing and Distribution of Panretin.
Feb 03, 1999: Panretin receives FDA approval
Aug 05, 1997: Taxol Approved for Kaposi\'s Sarcoma

Contact US:

Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales(at)marketresearchreports.biz
Blog: http://mresearchreports.blogspot.com